Limitations of Current Therapeutic Options to Manage MS and Disability Progression
Addressing the Unmet Needs of Myotonic Dystrophy Type 1 (DM1)
Beyond Routine Recovery: Treating Atypical Postpartum Complications
Webinar | Oncology | 1.0 - 60 mins | Hematology | Biosimilars | BiosimilarsCME.org | Online |
A ACCME Accredited provider.
The France Foundation ©
Chandler Building, 84 Lyme Street, Old Lyme, CT USA